Malaria Vaccine Current Events | Malaria Vaccine News | 9
|
| Page
9 of
45 |
885 Results |
|
|
|
Sort By:
Page Views | Date |
New malaria enzyme laid bare with help of computer calculations
Using only computers, a research team at Uppsala University in Sweden has managed to reveal both the structure and the function of a newly discovered enzyme from the most dangerous malaria parasite, Plasmodium falciparum. All that was needed was the amino acid sequence of the enzyme. The findings may represent a breakthrough for future... view more... (2004-12-07)
TB vaccine developed at McMaster University in Canada
McMaster University researchers are about to launch Canada's first tuberculosis (TB) vaccine clinical trial with a vaccine totally designed, manufactured and tested within McMaster. view more (2009-03-20)
Animal model shows early promise for SARS vaccine (p 1895)
Embargoed 0001 h (London time) 5 December 2003. US authors of a research letter in this week's issue of THE LANCET highlight preliminary findings which could mark an important step in the development of a human vaccine for severe acute respiratory syndrome (SARS). A genetically engineered vaccine was found to be effective in triggering an immune... view more... (2003-12-03)
Meningitis: effectiveness of preventive vaccination demonstrated
Meningitis epidemics caused by the pathogen Nesseiria meningitis (or meningococcus) provoke high mortality in children and young people under 20 years of age in sub-Saharan Africa. view more (2007-06-06)
Influenza vaccine causes weaker immune response for rural children
Researchers have found that vaccination against influenza strains seems to be more effective in a semi-urban population than in a rural population of schoolchildren in Gabon, Africa, according to an article in the Dec. 1 issue of The Journal of Infectious Diseases. view more (2007-10-23)
Major advance in the treatment of severe malaria in our region
A drug derived from an ancient Chinese herb has been shown to reduce the risk of death from severe malaria by a third, potentially saving hundreds of thousands of lives in nations on our doorstep. view more (2005-08-29)
UCSB researchers develop cross-protective vaccine
Doctors have always hoped that scientists might one day create a vaccination that would treat a broad spectrum of maladies. They could only imagine that there might be one vaccine that would protect against, say, 2,500 strains of Salmonella. view more (2008-10-22)
New rabies vaccine may require only a single shot... not 6
A person, usually a child, dies of rabies every 20 minutes. However, only one inoculation may be all it takes for rabies vaccination, according to new research published in the Journal of Infectious Diseases by researchers at the Jefferson Vaccine Center. view more (2009-09-21)
On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. view more (2009-11-20)
Research exposes new target for malaria drugs
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development. view more (2008-08-05)
Smokers invite to test vaccine against nicotine addiction
UCSF's Habit Abatement Clinic is testing a vaccine that enlists help from the immune system to keep nicotine away from the brain. The vaccine is designed to help smokers quit and to limit the urge to start smoking again. view more (2006-06-12)
Clinical trial evaluating brain cancer vaccine is underway at NYU
A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. view more (2007-10-22)
Entomologists exonerate mosquito in Kentish marshland killings
Medical entomologists believe that they have got to the bottom of the unusually high death rates recorded in the marshes around the River Thames, and the Essex and Kent coasts between 1700 and 1925. And for once the mosquito is not to blame. Speaking at the Royal Entomological Society’s national meeting Entomology 2002, which will take place... view more... (2002-09-04)
Multilateral initiative on malaria seeks international effort
Achieving victory over malaria in Africa, a disease that each year kills millions and imposes costs that cripple entire economies, requires a new internationally funded effort dedicated to training and supporting a critical mass of African malaria researchers. view more (2005-11-14)
Portuguese and British scientists develop mathematical model that explains variability in tuberculosis vaccine efficacy
Scientists at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, together with colleagues at the Universities of Lisbon and Warwick, in the United Kingdom, have developed a mathematical model that explains why the tuberculosis (TB) vaccine is ineffective in many of the developing countries. The model quantifies the predicted decrease in the... view more... (2004-03-03)
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily... view more... (2008-08-28)
College students who feel 'invincible' unlikely to accept vaccines, MU researcher finds
Vaccines to protect against sexually transmitted diseases, including HIV and herpes, are being developed and may soon be available to college students. view more (2009-07-30)
Malaria Millennium Development Goal 'unlikely to be met'
The Millennium Development Goal (MDG) to halt and begin to reverse the incidence of malaria globally is unlikely to be met, according to Wellcome Trust Principal Research Fellow Professor Bob Snow. view more (2008-07-22)
New MUHC study adds more evidence to clear measles mumps rubella vaccine as a risk factor for autism
A new MUHC study provides conclusive evidence that the Measles Mumps Rubella (MMR) vaccine is not associated with the development of autism spectrum disorders (ASDs). view more (2006-10-18)
UNC, Harvard develop inhaled TB vaccine
A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide. view more (2008-03-17)
|
|
| Page
9 of
45 |
885 Results |
|
|
|
Sort By:
Page Views | Date |
|
